Big data, electronic health records, online health insurance portals-countless technology innovations are emerging, but how important are they for health leaders to adopt? According to analysts at Forrester Research, a global research and advisory firm, it's not only extremely imperative, but a matter of organizational survival.
Big data, electronic health records, online health insurance portals—countless technology innovations are emerging, but how important are they for health leaders to adopt? According to analysts at Forrester Research, a global research and advisory firm, it’s not only extremely imperative, but a matter of organizational survival.
“In no other industry has technology been called on to so significantly alter the fundamental relationships that are occurring in the delivery of healthcare today,” said Skip Snow, a senior analyst at Forrester. “Technology has frequently been managed on a case-by-case, need-by-need basis without a strong road map being in place, which is the core of good enterprise architecture.”
So what can healthcare providers do to adapt and evolve with health technology? Forrester offers these 5 suggestions:
Mr Snow says that it is only a matter of time before health information technology is fully integrated into healthcare business models. It will eventually allow physicians and practices to focus their attention on more pressing matters. He adds that is “another way that cost can be taken out of the system.”
Around the Web
Forrester Outlines IT Imperatives for Healthcare Providers [CIO]
Gov. Mandates, Data Proliferation Keep CIOs up at Night [FireceHealth IT]
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More